Health Care & Life Sciences » Pharmaceuticals | Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd.
Stock Exchange Australian Stock Exchange
EPS
 AUD0.02
Market Cap
 AUD26.63 M
Shares Outstanding
 80.1 M
Public Float
 -

Profile

Address
QEII Medical Centre
Perth Western Australia (WA) 6009
Australia
Employees -
Website http://www.proteomics.com.au
Updated 07/08/2019
Proteomics International Laboratories Ltd. is a biological research and drug discovery company. It operates through three synergistic business units: Analytical services, Diagnostics and Therapeutics. The Analytical services unit engages in contract research, analytical testing and consultancy.

Financials

View All
Created with Highcharts 5.0.14Proteomics International Laboratories Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.2512511 1491 1491 3281 3289169161 4401 4402014201520162017201802505007501000125015001750
Created with Highcharts 5.0.14Proteomics International Laboratories Ltd.Sales/Revenue. Fiscal year is July-June. All values AUD Thousands.4764766086088168169259251 1761 17620142015201620172018025050075010001250

Richard Lipscombe
Managing Director & Director
Paul House
Non-Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.